GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 117 filers reported holding GENOMIC HEALTH INC in Q3 2015. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $17,996,000 | -55.2% | 265,344 | -61.6% | 0.01% | -58.3% |
| Q2 2019 | $40,194,000 | -26.3% | 690,982 | -11.3% | 0.01% | -25.0% |
| Q1 2019 | $54,555,000 | +28.7% | 778,799 | +18.4% | 0.02% | +14.3% |
| Q4 2018 | $42,384,000 | -9.9% | 658,036 | -1.8% | 0.01% | +16.7% |
| Q3 2018 | $47,032,000 | +51.7% | 669,774 | +8.9% | 0.01% | +50.0% |
| Q2 2018 | $31,006,000 | +134.8% | 615,202 | +45.8% | 0.01% | +166.7% |
| Q1 2018 | $13,204,000 | -4.5% | 422,005 | +4.4% | 0.00% | 0.0% |
| Q4 2017 | $13,826,000 | -4.2% | 404,243 | -10.1% | 0.00% | -25.0% |
| Q3 2017 | $14,432,000 | +19.6% | 449,756 | +21.3% | 0.00% | +33.3% |
| Q2 2017 | $12,070,000 | +30.4% | 370,806 | +26.1% | 0.00% | 0.0% |
| Q1 2017 | $9,259,000 | +48.2% | 294,048 | +38.3% | 0.00% | +50.0% |
| Q4 2016 | $6,249,000 | +26.2% | 212,623 | +24.2% | 0.00% | +100.0% |
| Q3 2016 | $4,952,000 | +70.6% | 171,218 | +52.8% | 0.00% | 0.0% |
| Q2 2016 | $2,902,000 | +43.1% | 112,057 | +36.9% | 0.00% | 0.0% |
| Q1 2016 | $2,028,000 | -13.0% | 81,866 | +23.6% | 0.00% | – |
| Q4 2015 | $2,331,000 | -43.1% | 66,231 | -65.8% | 0.00% | -100.0% |
| Q3 2015 | $4,099,000 | -57.1% | 193,756 | -43.6% | 0.00% | -50.0% |
| Q2 2015 | $9,550,000 | +52.8% | 343,689 | +68.0% | 0.00% | +100.0% |
| Q1 2015 | $6,249,000 | +29.7% | 204,534 | +35.7% | 0.00% | 0.0% |
| Q4 2014 | $4,818,000 | -39.6% | 150,720 | -46.5% | 0.00% | -50.0% |
| Q3 2014 | $7,971,000 | +307.9% | 281,565 | +294.7% | 0.00% | +100.0% |
| Q2 2014 | $1,954,000 | +7.5% | 71,341 | +3.4% | 0.00% | 0.0% |
| Q1 2014 | $1,817,000 | -64.2% | 68,980 | -60.2% | 0.00% | -50.0% |
| Q4 2013 | $5,079,000 | -11.0% | 173,517 | -7.0% | 0.00% | 0.0% |
| Q3 2013 | $5,707,000 | -40.3% | 186,626 | -38.1% | 0.00% | -50.0% |
| Q2 2013 | $9,559,000 | +91.3% | 301,414 | +64.3% | 0.00% | +100.0% |
| Q4 2012 | $4,998,000 | +26.1% | 183,490 | +60.6% | 0.00% | 0.0% |
| Q3 2012 | $3,963,000 | +50.5% | 114,233 | +44.9% | 0.00% | +100.0% |
| Q2 2012 | $2,633,000 | +54.2% | 78,832 | +41.3% | 0.00% | 0.0% |
| Q1 2012 | $1,707,000 | – | 55,782 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $56,620,000 | 5.32% |
| Baker Brothers Advisors | 13,655,618 | $386,590,000 | 4.87% |
| NORTH TIDE CAPITAL, LLC | 1,500,000 | $42,465,000 | 3.24% |
| Murphy Michael R | 291,292 | $8,246,000 | 2.85% |
| Tributary Capital Management, LLC | 111,244 | $3,149,000 | 0.66% |
| Champlain Investment Partners, LLC | 1,234,780 | $34,957,000 | 0.61% |
| IRONBRIDGE CAPITAL MANAGEMENT LP | 454,085 | $12,855,000 | 0.34% |
| STONEBRIDGE CAPITAL MANAGEMENT INC | 27,180 | $769,000 | 0.30% |
| Motley Fool Asset Management LLC | 36,179 | $1,139,000 | 0.24% |
| Kimelman & Baird, LLC | 35,800 | $1,013,000 | 0.19% |